Related Experiment Video

Updated: Jun 25, 2026

Robust Detection of Gene Amplification in Formalin-Fixed Paraffin-Embedded Samples by Fluorescence In Situ Hybridization
03:55

Robust Detection of Gene Amplification in Formalin-Fixed Paraffin-Embedded Samples by Fluorescence In Situ Hybridization

Published on: July 12, 2024

A reason why the ERBB2 gene is amplified and not mutated in breast cancer

Daniel Birnbaum1, Fabrice Sircoulomb, Jean Imbert

  • 1Centre de Recherche en Cancérologie de Marseille, UMR891 Inserm and Institut Paoli-Calmettes, Marseille, F-13009, France. daniel.birnbaum@inserm.fr

Cancer Cell International
|February 20, 2009
PubMed

Insights

Gene amplification of ERBB2 (a receptor-type tyrosine kinase) in breast cancer may overcome repression by transcription factors. This study explores why ERBB2 amplification occurs in certain cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Receptor-type tyrosine kinases (RTK) alterations are common in human cancers, arising from translocations, mutations, or amplifications.
  • The ERBB2 RTK gene is amplified in approximately 20% of breast cancer cases.
  • The specific mechanism driving ERBB2 amplification remains an area of investigation.

Purpose of the Study:

  • To investigate the underlying reasons for the specific amplification of the ERBB2 gene in breast cancer.
  • To test the hypothesis that ERBB2 gene amplification serves to counteract transcriptional repression.

Main Methods:

  • The study proposes a hypothesis regarding gene amplification.
  • Further research would involve analyzing gene expression patterns and transcription factor binding in relation to ERBB2 amplification.

Main Results:

  • The proposed mechanism suggests that ERBB2 amplification is a strategy to overcome repression by sequence-specific transcription factors.
  • This amplification allows for increased expression of the ERBB2 RTK.

Conclusions:

  • ERBB2 gene amplification in breast cancer may be a mechanism to escape transcriptional repression.
  • Understanding this mechanism could offer insights into targeted cancer therapies.

More Related Videos

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...